MTOR and neoplasm: Focused on pNETs, Missiaglia et al. discovered that the downregulation of TSC2 and PTEN affects many of the sporadic cases with percentages of 35% and 60% of patients, respectively, and low levels of these components may help tumor cells to escape the mTOR inhibition [21].